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ABSTRACT  
The   aim   of   this   thesis   was   to   describe   the   consequences   of   being   diagnosed   with  
hypertrophic   cardiomyopathy   (HCM)   while   being   asymptomatic,   taking   into  
consideration  psychosocial  effects  and  medical  aspects  of  diagnosis  and  treatment.    
Methods:   Quality   of   life   (QoL)   was   measured   according   to   Lindström   before   the  
diagnosis,   and   after   two   years,   comparing   with   healthy   controls.   Psychosocial  
consequences  of   the  diagnosis  were   explored   in   interviews  with   children  and   their  
parents  and  analysed  using  content  analysis.  Exercise  performance  was  measured  at  
baseline  and  after  one  year  in  patients  randomized  to  no  pharmacological  treatment  
or  selective  or  non-­‐‑selective  high-­‐‑dose  beta-­‐‑blocker  therapy.    
Results:  The  total  QoL  score  was  similar  in  both  groups  at  baseline  and  at  follow-­‐‑up.  
Parents  described  an  immediate  reaction  of  shock,  grief  and  feelings  of  injustice  but  
were  also  grateful   that   their  child  had  been  diagnosed  and  was  still  asymptomatic.  
The   diagnosis   resulted   in   a   change   in   life-­‐‑style   for   most   families   due   mainly   to  
restrictions  of   sports   activities.  Parents  had  difficulties   to   adapt   to   the  new   life  but  
after   re-­‐‑adjustment   they   regained  hope  and  confidence.     The  children  described  an  
involuntary  change  of  their  daily  life  with  limitations  and  restrictions  because  of  life-­‐‑
style   recommendations   and   this   also   affected   their   social   context.  However,   after   a  
reorientation   process   they   felt   hope   and   had   faith   in   the   future.   There   was   no  
significant  difference  in  exercise  capacity  between  the  groups  at  baseline,  or  after  one  
year  of  observation  versus  beta-­‐‑blocker  treatment.    
Conclusions:  Family  screening  for  HCM  did  not  appear  to  negatively  influence  QoL.  
Children   diagnosed   with   HCM   through   family   screening   went   through   an  
involuntary   change   of   daily   life,   mainly   ascribed   to   life-­‐‑style-­‐‑modifications.   They  
strived  to  create  a  life  where  they  could  feel  secure  and  have  faith  in  the  future,  and  
with  the  support  of  parents  and  health  care  professionals  they  achieved  a  new  state  
of   normality.   Neither   selective   nor   non-­‐‑selective   beta-­‐‑blockade   caused   significant  
reductions  in  exercise  capacity  in  patients  with  HCM  above  that  induced  by  life-­‐‑style  
changes.  
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